QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 wells-fargo-maintains-overweight-on-enovis-raises-price-target-to-42

Wells Fargo analyst Vik Chopra maintains Enovis (NYSE:ENOV) with a Overweight and raises the price target from $41 to $42.

 enovis-raises-fy2025-adj-eps-guidance-from-305-320-to-310-325-vs-312-est-lowers-fy2025-sales-guidance-from-2245b-2275b-to-2240b-2270b-vs-2255b-est

Enovis (NYSE:ENOV) raises FY2025 Adj EPS guidance from $3.05-$3.20 to $3.10-$3.25 vs $3.12 analyst estimate. Lowers FY2025 sale...

 enovis-q3-adj-eps-075-beats-065-estimate-sales-548912m-beat-538617m-estimate

Enovis (NYSE:ENOV) reported quarterly earnings of $0.75 per share which beat the analyst consensus estimate of $0.65 by 15.56 p...

 canaccord-genuity-maintains-buy-on-enovis-lowers-price-target-to-58

Canaccord Genuity analyst Caitlin Cronin maintains Enovis (NYSE:ENOV) with a Buy and lowers the price target from $70 to $58.

 ubs-maintains-buy-on-enovis-lowers-price-target-to-57

UBS analyst Danielle Antalffy maintains Enovis (NYSE:ENOV) with a Buy and lowers the price target from $65 to $57.

 wells-fargo-maintains-overweight-on-enovis-lowers-price-target-to-41

Wells Fargo analyst Vik Chopra maintains Enovis (NYSE:ENOV) with a Overweight and lowers the price target from $48 to $41.

 enovis-raises-fy2025-adj-eps-guidance-from-295-310-to-305-320-vs-303-est-raises-fy2025-sales-guidance-from-2220b-2250b-to-2245b-2275b-vs-2236b-est

2025 Financial OutlookEnovis updated financial expectations for 2025. Revenue is expected to be in the range of $2.245-2.275 bi...

 enovis-q2-adj-eps-079-beats-071-estimate-sales-564545m-beat-554613m-estimate

Enovis (NYSE:ENOV) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.71 by 10.49 p...

 jehoshaphat-research-posts-on-x-we-are-short-enovis-enov-a-roll-up-of-health-care-businesses-thats-easy-to-borrow-below-is-just-a-summary-of-the-key-opinions-in-this-idea-for-the-full-short-thesis-including-a-downloadable-pdf-please-see-the-jehoshaphat-research-site

https://x.com/jehoshaphatrsch/status/1945841045884875234?s=46&t=dtUiyC3dUs5yGRgT9qYHWg

 evercore-isi-group-maintains-outperform-on-enovis-lowers-price-target-to-46

Evercore ISI Group analyst Vijay Kumar maintains Enovis (NYSE:ENOV) with a Outperform and lowers the price target from $48 t...

 canaccord-genuity-maintains-buy-on-enovis-lowers-price-target-to-70

Canaccord Genuity analyst Caitlin Cronin maintains Enovis (NYSE:ENOV) with a Buy and lowers the price target from $75 to $70.

 where-enovis-stands-with-analysts
Where Enovis Stands With Analysts
05/09/2025 21:00:46

 jmp-securities-maintains-market-outperform-on-enovis-lowers-price-target-to-55

JMP Securities analyst David Turkaly maintains Enovis (NYSE:ENOV) with a Market Outperform and lowers the price target from ...

 needham-maintains-buy-on-enovis-lowers-price-target-to-57

Needham analyst Mike Matson maintains Enovis (NYSE:ENOV) with a Buy and lowers the price target from $64 to $57.

 enovis-lowers-fy2025-adj-eps-guidance-from-310-325-to-295-310-vs-318-est-raises-fy2025-sales-guidance-from-219b-222b-to-222b-225b-vs-221b-est

Enovis updated financial expectations for 2025. Revenue is expected to be in the range of $2.22-2.25 billion, versus prior expe...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION